Mathias Oelke Department of Pathology, Institute of Cell Engineering Johns Hopkins University Biography Publications Institution JoVE Articles Mathias Oelke has not added a biography. If you are Mathias Oelke and would like to personalize this page please email our Author Liaison for assistance. Publications IL-2 Upregulates CD86 Expression on Human CD4+ and CD8+ T Cells Journal of Immunology (Baltimore, Md. : 1950). Feb, 2012 | Pubmed ID: 22246628 Heat Shock Protein 70/peptide Complexes: Potent Mediators for the Generation of Antiviral T Cells Particularly with Regard to Low Precursor Frequencies Journal of Translational Medicine. 2011 | Pubmed ID: 21992180 Decline of Influenza-specific CD8+ T Cell Repertoire in Healthy Geriatric Donors Immunity & Ageing : I & A. 2011 | Pubmed ID: 21846352 Killer Artificial Antigen-presenting Cells: the Synthetic Embodiment of a 'guided Missile' Immunotherapy. Jul, 2010 | Pubmed ID: 20636007 Dietary Fatty Acids Modulate Antigen Presentation to Hepatic NKT Cells in Nonalcoholic Fatty Liver Disease Journal of Lipid Research. Jul, 2010 | Pubmed ID: 20185414 Dynamic Regulation of Functionally Distinct Virus-specific T Cells Proceedings of the National Academy of Sciences of the United States of America. Feb, 2010 | Pubmed ID: 20133680 Overview of a HLA-Ig Based "Lego-like System" for T Cell Monitoring, Modulation and Expansion Immunologic Research. Jul, 2010 | Pubmed ID: 20087680 Soluble Recombinant CMVpp65 Spanning Multiple HLA Alleles for Reconstitution of Antiviral CD4+ and CD8+ T-cell Responses After Allogeneic Stem Cell Transplantation Journal of Immunotherapy (Hagerstown, Md. : 1997). Jan, 2010 | Pubmed ID: 19952955 In Vivo Administration of Artificial Antigen-presenting Cells Activates Low-avidity T Cells for Treatment of Cancer Cancer Research. Dec, 2009 | Pubmed ID: 19934317 Ovarian Cancer-associated Ascites Demonstrates Altered Immune Environment: Implications for Antitumor Immunity Anticancer Research. Aug, 2009 | Pubmed ID: 19661290 Development of an Artificial-antigen-presenting-cell-based Assay for the Detection of Low-frequency Virus-specific CD8(+) T Cells in Whole Blood, with Application for Measles Virus Clinical and Vaccine Immunology : CVI. Jul, 2009 | Pubmed ID: 19494085 Ex Vivo Induction and Expansion of Natural Killer T Cells by CD1d1-Ig Coated Artificial Antigen Presenting Cells Journal of Immunological Methods. Jul, 2009 | Pubmed ID: 19446558 In Vivo Functional Efficacy of Tumor-specific T Cells Expanded Using HLA-Ig Based Artificial Antigen Presenting Cells (aAPC) Cancer Immunology, Immunotherapy : CII. Feb, 2009 | Pubmed ID: 18563409 Ascites Specific Inhibition of CD1d-mediated Activation of Natural Killer T Cells Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Dec, 2008 | Pubmed ID: 19047090 Killer Artificial Antigen-presenting Cells: a Novel Strategy to Delete Specific T Cells Blood. Apr, 2008 | Pubmed ID: 18096763 Expansion of Human Cytomegalovirus-specific T Lymphocytes from Unfractionated Peripheral Blood Mononuclear Cells with Artificial Antigen-presenting Cells Transfusion. Nov, 2007 | Pubmed ID: 17958544 Differential Innate Immune Cell Activation and Proinflammatory Response in Anaplasma Phagocytophilum Infection Infection and Immunity. Jun, 2007 | Pubmed ID: 17403880 Evaluation of Topoisomerase-1-specific CD8+ T-cell Response in Systemic Sclerosis Annals of the New York Academy of Sciences. Dec, 2005 | Pubmed ID: 16461796 Artificial Antigen-presenting Cells: Artificial Solutions for Real Diseases Trends in Molecular Medicine. Sep, 2005 | Pubmed ID: 16103011 Technological Advances in Adoptive Immunotherapy Drugs of Today (Barcelona, Spain : 1998). Jan, 2005 | Pubmed ID: 15753966 Immunotherapy with Enhanced Self Immune Cells Discovery Medicine. Jun, 2004 | Pubmed ID: 20704987 Intracranial Aspergillosis in a Non-immunocompromised Patient Treated for Muscle-invasive Bladder Cancer International Journal of Urology : Official Journal of the Japanese Urological Association. Aug, 2004 | Pubmed ID: 15285760 Quality and Quantity: New Strategies to Improve Immunotherapy of Cancer Trends in Molecular Medicine. May, 2004 | Pubmed ID: 15121045 HLA-Ig-based Artificial Antigen-presenting Cells: Setting the Terms of Engagement Clinical Immunology (Orlando, Fla.). Mar, 2004 | Pubmed ID: 15047202 Identification of Beta-subunit of Bacterial RNA-polymerase--a Non-species-specific Bacterial Protein--as Target of Antibodies in Primary Biliary Cirrhosis Digestive Diseases and Sciences. Mar, 2003 | Pubmed ID: 12757171 Ex Vivo Induction and Expansion of Antigen-specific Cytotoxic T Cells by HLA-Ig-coated Artificial Antigen-presenting Cells Nature Medicine. May, 2003 | Pubmed ID: 12704385 Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells Christian Schütz1, Martin Fleck2,3, Jonathan P. Schneck1, Mathias Oelke1 1Department of Pathology, Institute of Cell Engineering, Johns Hopkins University, 2Department of Internal Medicine I, University of Regensburg, 3Department of Rheumatology, Asklepios Medical Center JoVE 51859 Immunology and Infection HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL Yen-Ling Chiu1,2, Jonathan P. Schneck3,4, Mathias Oelke3,4 1Immunology Graduate Program, Johns Hopkins University, 2Department of Internal Medicine, Far-Eastern Memorial Hospital, 3Department of Pathology, Johns Hopkins University, 4Institute of Cell Engineering, Johns Hopkins University JoVE 2801 Immunology and Infection
Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells Christian Schütz1, Martin Fleck2,3, Jonathan P. Schneck1, Mathias Oelke1 1Department of Pathology, Institute of Cell Engineering, Johns Hopkins University, 2Department of Internal Medicine I, University of Regensburg, 3Department of Rheumatology, Asklepios Medical Center JoVE 51859 Immunology and Infection
HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL Yen-Ling Chiu1,2, Jonathan P. Schneck3,4, Mathias Oelke3,4 1Immunology Graduate Program, Johns Hopkins University, 2Department of Internal Medicine, Far-Eastern Memorial Hospital, 3Department of Pathology, Johns Hopkins University, 4Institute of Cell Engineering, Johns Hopkins University JoVE 2801 Immunology and Infection
